Molecular diagnostic company Asuragen has appointed Rollie Carlson to president and CEO, replacing founder Matt Winkler, who will retain the role of chairman of the board and chief scientific officer.

Carlson was previously the president and chief operating officer of Asuragen. Prior to joining the company in 2006, he held several positions at Abbott Laboratories, including vice president and general manager of the Vysis molecular diagnostic business following its acquisition by Abbott.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.